M1 Macrophages Induce PD-L1 Expression in Hepatocellular Carcinoma Cells Through IL-1β Signaling
Hepatocellular carcinoma (HCC) is a prototype of inflammation-related cancer, harboring M1-like and M2-like tumor-associated macrophages. M1 macrophages are thought to be tumoricidal, but some studies report its pro-tumor role. The programmed cell death-ligand (PD-L) 1 expressed in HCC cells is a critical checkpoint molecule to mediate immune escape of HCC. The PD-L1 expression in HCC cells is inducible. In the present study, we ask whether M1 macrophages induce the expression of PD-L1 in HCC cells. First, an association between M1 macrophage infiltration and PD-L1 expression in HCC tissues was determined by bioinformatics and immunohistochemistry experiments. The enrichment score of M1 macrophages was correlated to PD-L1 expression in 90 HCC samples from GEO database. Besides, infiltration of CD68+HLA-DR+ M1-like macrophages correlated with PD-L1 expression level in HCC cells. Moreover, M1-conditioned media was prepared from M1 macrophages derived from THP-1 cell, RAW264.7 cell or murine bone marrow. These supernatants induced expression of PD-L1 in HCC cells. Furthermore, inflammatory cytokine IL-1β in the supernatants was identified to account for the inducible PD-L1 expression by siRNA assay and receptor blockade assay. Additionally, transcription factor p65 and IRF1 in the HCC cells were revealed by CHIP assay to mediate the inducible PD-L1 expression. All the results demonstrate that M1 macrophages induced expression of PD-L1 in HCC cells, supporting the pro-tumor role of M1 macrophages.
CITE THIS COLLECTION
REFERENCES
- https://doi.org//10.1016/S0140-6736(18)30010-2
- https://doi.org//10.1016/j.immuni.2014.07.009
- https://doi.org//10.1016/j.addr.2015.11.009
- https://doi.org//10.1158/0008-5472.CAN-17-3480
- https://doi.org//10.1002/ijc.28736
- https://doi.org//10.1016/j.canlet.2013.11.013
- https://doi.org//10.1002/hep.28803
- https://doi.org//10.1002/hep.28710
- https://doi.org//10.1172/JCI80011
- https://doi.org//10.1007/s00262-018-2226-9
- https://doi.org//10.1080/2162402X.2016.1181252
- https://doi.org//10.1186/s13059-017-1349-1
- https://doi.org//10.3892/ijo.2013.2203
- https://doi.org//10.1111/j.1365-2567.2010.03357.x
SHARE
Usage metrics
Read the peer-reviewed publication
![Frontiers in Immunology](https://s3-eu-west-1.amazonaws.com/876az-branding-figshare/frontiers/logo.png)
AUTHORS (10)
CATEGORIES
- Transplantation Immunology
- Tumour Immunology
- Immunology not elsewhere classified
- Immunology
- Veterinary Immunology
- Animal Immunology
- Genetic Immunology
- Applied Immunology (incl. Antibody Engineering, Xenotransplantation and T-cell Therapies)
- Autoimmunity
- Cellular Immunology
- Humoural Immunology and Immunochemistry
- Immunogenetics (incl. Genetic Immunology)
- Innate Immunity